What Is Abaxis 2.5 Mg – Apixaban?

Abaxis 2.5 Mg – Apixaban is an oral anticoagulant medicine belonging to the class of Direct Oral Anticoagulants (DOACs). It contains apixaban, a clinically studied agent that helps reduce the risk of harmful blood clots by targeting Factor Xa in the coagulation pathway.

It is typically prescribed for:

• Stroke prevention in non-valvular atrial fibrillation

• Treatment of deep vein thrombosis (DVT)

• Treatment of pulmonary embolism (PE)

• Prevention of recurrent DVT and PE

• Post-operative clot prevention after hip or knee replacement surgery

This medication should be used strictly under the supervision of a qualified healthcare professional.

Mechanism of Action

Apixaban works through:

1. Selective Factor Xa Inhibition

Factor Xa plays a key role in converting prothrombin to thrombin during blood clot formation. Apixaban blocks this enzyme, reducing thrombin generation and clot development.

2. Controlled Anticoagulation

Unlike vitamin K antagonists, apixaban provides predictable anticoagulation without routine INR monitoring in most patients.

3. Reduced Stroke Risk

In atrial fibrillation, preventing clot formation significantly lowers stroke risk when used appropriately.

Indications

A healthcare provider may prescribe Abaxis 2.5 Mg – Apixaban for:

• Prevention of stroke and systemic embolism in atrial fibrillation

• Treatment of DVT

• Treatment of PE

• Prevention of recurrent venous thromboembolism

• Thromboprophylaxis following orthopedic surgery

Dosage and duration depend on clinical evaluation and risk assessment.

Dosage & Administration

• Take exactly as prescribed by your clinician

• Swallow tablet whole with water

• Can be taken with or without food

• Do not skip doses

• Do not stop suddenly without medical advice

Abrupt discontinuation may increase clot risk.

Safety Information & Precautions

Before starting therapy, inform your healthcare provider if you have:

• Active bleeding

• Liver disease

• Kidney impairment

• History of stroke

• Recent surgery

Bleeding disorders

Global respiratory disease prevention and treatment frameworks are supported by public health resources from WHO – Respiratory Disease Information.

Important Safety Notes

• Increased risk of bleeding

• Emergency care may be required for major bleeding

• Inform doctors before any surgery or dental procedure

Possible Side Effects

Commonly reported side effects may include:

• Minor bleeding (nose, gums)

• Bruising

• Nausea

• Anemia

Seek immediate medical attention for:

• Severe bleeding

• Blood in urine or stool

• Sudden severe headache

• Unusual weakness

Drug Interactions

Use caution with:

• Other anticoagulants

• Antiplatelet medications

• NSAIDs

• Certain antifungal or antiviral medications

Always disclose all medications and supplements to your healthcare provider.

Neuropsychiatric medication coordination in long-term treatment planning may also include therapeutic support options such as Amisulpride 100 Mg under professional medical supervision.

Use in Special Populations

Pregnancy & Breastfeeding

Consult a healthcare professional before use.

Elderly Patients

May require careful bleeding risk assessment.

Renal or Hepatic Impairment

Dose adjustments may be necessary.

Monitoring & Follow-Up

While routine INR testing is not typically required:

• Periodic kidney and liver function tests may be recommended

• Monitor for signs of bleeding

• Regular follow-up appointments are important

   

Long-term cardiovascular therapy monitoring may also include beta-blocker support options such as Carvedilol 3.125 Mg – Coreg under professional supervision.

Storage Instructions

• • Store below 25°C

  • Protect from moisture and sunlight

  • Keep out of reach of children

  • Do not use after expiry date

    FAQs